2023
-
Poster Spotlight Session 17: Biomarkers of Response and/or Resistance to Endocrine Based Therapies: Implications for Treatment Approaches – Presenter Profiles
Sacha Howell, PhD, FRCP, and Angel Guerrero-Zotano, MD, PhD, discuss their Friday morning poster presentations.
-
Poster Spotlight Session 18: Disparate Care Calls for Desperate Measures: Understanding Gaps in Quality of Care and Opportunities to Improve it – Presenter Profiles
Malcolm Bevel, PhD, MSPH; Richard J. Bleicher, MD, FACS; and Marcela Mazo-Canola, MD, discuss their Friday morning poster presentations.
-
General Session 1 includes results from HER2CLIMB-02, MONARCH 3 trials
Findings from the HER2CLIMB-02 trial and late-breaking final overall survival results from MONARCH 3 were presented on Wednesday during the first General Session of the 2023 SABCS®.
-
McGuire Memorial Award lecturer, Jack Cuzick, PhD, reviews data on breast cancer prevention
Jack Cuzick, PhD, a pioneer in breast cancer prevention research, received the William L. McGuire Memorial Lecture Award on Wednesday.
-
SABCS® Daily Highlights for Thursday, December 7
SABCS® Program Director Kate Lathrop, MD, shares a few highlights from Thursday’s schedule to help you plan your day, including Poster Spotlight Sessions and notable General Session abstracts.
-
Thursday General Session and Poster Spotlight Session presentations
Don’t miss Thursday’s General Session abstract presentations and Poster Spotlight Session presentations, featuring research that has the potential to shape the future of breast cancer care.
-
Inflammatory Breast Cancer: Clinical Challenges, Evolving Concepts and Novel Treatments (People’s Choice) – Presenter Profile
Frederick Howard, MD, discusses a Thursday afternoon presentation on whether inflammatory breast cancer is a genomically different type of breast cancer.
-
Poster Spotlight Session 13: Special Populations: Pregnancy, Male and Geriatric Patients – Presenter Profile
Carsten F.J. Bakhuis discusses a Thursday evening poster presentation on worse prognosis for breast cancer in the second and third trimesters of pregnancy and shortly postpartum.
-
Poster Spotlight Session 14: Setting Expectations for Toxicities Related to I/O Therapy – Presenter Profile
Neelima Vidula, MD, discusses a Thursday evening poster presentation on immune related adverse events in patients over 65 years of age vs. those younger than 65 years with breast cancer who were treated with immunotherapy.
-
Poster Spotlight Session 15: Novel Nuclear Receptor Targeting Therapies – Presenter Profile
Erika Hamilton, MD, discusses a Thursday evening poster presentation on the activity of ARV-471 in combination with a CDK4/6 inhibitor in patients with HR+ metastatic breast cancer.